Daniel R Scoles

Daniel R Scoles

UNVERIFIED PROFILE

Are you Daniel R Scoles?   Register this Author

Register author
Daniel R Scoles

Daniel R Scoles

Publications by authors named "Daniel R Scoles"

Are you Daniel R Scoles?   Register this Author

30Publications

323Reads

31Profile Views

Antisense therapies for movement disorders.

Mov Disord 2019 08 8;34(8):1112-1119. Epub 2019 Jul 8.

Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27782DOI Listing
August 2019

Antisense oligonucleotides: A primer.

Neurol Genet 2019 Apr 1;5(2):e323. Epub 2019 Apr 1.

Department of Neurology (D.R.S., S.M.P.), University of Utah, Salt Lake City, UT; and Center for the Science of Therapeutics (E.V.M.), Broad Institute of MIT and Harvard, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXG.0000000000000323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501637PMC
April 2019

Oligonucleotide therapeutics in neurodegenerative diseases.

RNA Biol 2018 1;15(6):707-714. Epub 2018 Jun 1.

a Department of Neurology , University of Utah , Salt Lake City , UT , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15476286.2018.1454812DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152438PMC
November 2018

Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration.

Nat Commun 2018 09 7;9(1):3648. Epub 2018 Sep 7.

Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-06041-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128856PMC
September 2018

Spinocerebellar Ataxia Type 2.

Adv Exp Med Biol 2018 ;1049:175-195

Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, UT, 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-71779-1_8DOI Listing
July 2018

Molecular dynamics analysis of the aggregation propensity of polyglutamine segments.

PLoS One 2017 25;12(5):e0178333. Epub 2017 May 25.

Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178333PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444867PMC
September 2017

Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.

Nature 2017 04 12;544(7650):362-366. Epub 2017 Apr 12.

Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature22044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625650PMC
April 2017

Effects of the enlargement of polyglutamine segments on the structure and folding of ataxin-2 and ataxin-3 proteins.

J Biomol Struct Dyn 2017 Feb 20;35(3):504-519. Epub 2016 May 20.

a Department of Biomedical Informatics , University of Utah , Salt Lake City , UT , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07391102.2016.1152199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580338PMC
February 2017

Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening.

PLoS One 2015 28;10(8):e0136930. Epub 2015 Aug 28.

Department of Neurology, University of Utah, 175 North Medical Center Drive East, 5th Floor, Salt Lake City, Utah, 84132, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0136930PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552753PMC
May 2016

Repeat Associated Non-AUG Translation (RAN Translation) Dependent on Sequence Downstream of the ATXN2 CAG Repeat.

PLoS One 2015 18;10(6):e0128769. Epub 2015 Jun 18.

Department of Neurology, University of Utah, 175 North Medical Drive East, 5th Floor, Salt Lake City, Utah, 84132, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128769PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472729PMC
April 2016

Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model.

PLoS Genet 2015 Apr 22;11(4):e1005182. Epub 2015 Apr 22.

Department of Neurology, University of Utah, Salt Lake City, Utah, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pgen.1005182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406435PMC
April 2015

ETS1 regulates the expression of ATXN2.

Hum Mol Genet 2012 Dec 21;21(23):5048-65. Epub 2012 Aug 21.

Department of Neurology, University of Utah, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/dds349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490512PMC
December 2012

Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein.

Gynecol Oncol 2010 Jan 24;116(1):109-16. Epub 2009 Oct 24.

Women's Cancer Research Institute and Division of Gynecologic Oncology, CSMC Burns and Allen Research Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082580900733
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2009.09.034DOI Listing
January 2010

Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas.

Clin Cancer Res 2008 Dec;14(23):7645-51

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars-Sinai Women's Cancer Research Institute, David Geffen School of Medicine at UCLA, Los Angeles, California 90048, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-08-1291DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677417PMC
December 2008

Impact of statin therapy on survival in epithelial ovarian cancer.

Gynecol Oncol 2008 Oct;111(1):102-5

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.06.007DOI Listing
October 2008

ERCC5 is a novel biomarker of ovarian cancer prognosis.

J Clin Oncol 2008 Jun;26(18):2952-8

Department of Obstetrics and Gynecology, Cedars-Sinai Women's Cancer Research Institute, Samuel Oschin Comprehensive Cancer Institute, David Geffen School of Medicine, University of California at Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.13.5806DOI Listing
June 2008

Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.

Gynecol Oncol 2008 May 18;109(2):220-5. Epub 2008 Apr 18.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.02.010DOI Listing
May 2008

The merlin interacting proteins reveal multiple targets for NF2 therapy.

Authors:
Daniel R Scoles

Biochim Biophys Acta 2008 Jan 12;1785(1):32-54. Epub 2007 Oct 12.

Women's Cancer Research Institute, CSMC Burns and Allen Research Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2007.10.001DOI Listing
January 2008

Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT.

Gynecol Oncol 2007 Jan 7;104(1):120-8. Epub 2006 Sep 7.

Women's Cancer Research Institute at Samuel Oschin Comprehensive Cancer Institute and Division of Gynecologic Oncology, CSMC Burns and Allen Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.07.023DOI Listing
January 2007

Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).

Hum Mol Genet 2006 Apr 23;15(7):1059-70. Epub 2006 Feb 23.

Division of Neurology, CSMC Burns and Allen Research Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddl021DOI Listing
April 2006

HRS inhibits EGF receptor signaling in the RT4 rat schwannoma cell line.

Biochem Biophys Res Commun 2005 Sep;335(2):385-92

Rose Moss Neurogenetics Laboratory and Division of Neurology, Burns and Allen Research Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2005.07.083DOI Listing
September 2005

Genetic heterogeneity of stably transfected cell lines revealed by expression profiling with oligonucleotide microarrays.

J Cell Biochem 2003 Dec;90(5):1068-78

Rose Moss Neurogenetics Laboratory for Parkinson and Related Diseases, CSMS Burns and Allen Research Institute, Division of Neurology, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, California 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.10712DOI Listing
December 2003

The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI.

Hum Mol Genet 2003 Oct 12;12(20):2587-97. Epub 2003 Aug 12.

Rose Moss Laboratory for Neurogenetics, Parkinson's and Related Diseases, Burns and Allen Research Institute, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/hmg/article-lookup/doi/10.1093/hmg/
Publisher Site
http://dx.doi.org/10.1093/hmg/ddg269DOI Listing
October 2003

Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling.

Hum Mol Genet 2002 Dec;11(25):3179-89

Cedars-Sinai Medical Center, School of Medicine, University of California at Los Angeles, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/11.25.3179DOI Listing
December 2002

Effects of Nf2 missense mutations on schwannomin interactions.

Biochem Biophys Res Commun 2002 Jan;290(1):366-74

Division of Neurology, Cedars-Sinai Medical Center, 1145E Medical Tower, 8631 West 3rd Street, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/bbrc.2001.6178DOI Listing
January 2002